Sryntek Pharmaceutical Private Limited

Sryntek Pharmaceutical Private Limited - pharma in Pune, Maharashtra, India. Directors, charges & compliance details.
CIN U24290PN2022PTC211142 Incorporated 10 May 2022 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹18.19 Lakh
▲ 28% YoY
Net profit · FY 2025
₹1,769
Net margin 0.1%
EBITDA · FY 2025
₹95,077
EBITDA margin 5.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Sryntek Pharmaceutical Private Limited

Data last updated:

Sryntek Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 May 2022.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2022PTC211142. Its GSTIN is 27ABICS4752M1ZQ (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santoshidevi Yadav and Santosh Jagatpal Yadav.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Milkat No.1627 Shop No.4 Manterwadi Haveli Pune Uruli Dewachi, Maharashtra, India – 412308.

As per the financials filed for FY 2025, the company reported a revenue of ₹18.19 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1,769 (net margin 0.1%) and EBITDA of ₹95,077 (EBITDA margin 5.2%).

Sryntek Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0261867).

Company details

CIN U24290PN2022PTC211142
Registration Number 211142
Incorporation Date 10 May 2022
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0261867

Recognitions & Rankings of Sryntek Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-MH-26-0261867

Contact details

Sryntek Pharmaceutical Private Limited's registered office is in Pune, Maharashtra.

  • Registered Address
    Milkat No.1627 Shop No.4 Manterwadi Haveli Pune Uruli Dewachi, Maharashtra, India – 412308
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Sryntek Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sryntek Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sryntek Pharmaceutical Private Limited, buy the company report.

Financials of Sryntek Pharmaceutical Private Limited

FY 2025 filings available

Sryntek Pharmaceutical Private Limited reported revenue of ₹18.19 Lakh (up 28% YoY) for FY 2025.

Revenue · FY 2025
₹18.19 Lakh ▲ 28%
Net profit · FY 2025
₹1,769 margin 0.1%
EBITDA · FY 2025
₹95,077 margin 5.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 28%
EBITDA CAGR growth
1 year
▲ 21%

Revenue rose 28% in the latest year. EBITDA rose 21% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹95,077
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1,769
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin5.2%
Net Profit Margin0.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sryntek Pharmaceutical Private Limited, buy the company report.

Board of directors of Sryntek Pharmaceutical Private Limited

Sryntek Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Santoshidevi YadavDirector10 May 20224 Years 5 MonthsCurrent
Santosh Jagatpal YadavDirector10 May 20224 Years 5 MonthsCurrent

Peer comparison

Sryntek Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vijay Remedies Limited₹18.31 Lakh (FY 2025)167.0%Delhi, India
Stepan Laboratories Private Limited₹18.27 Lakh (FY 2025)-76.0%New Delhi, Delhi, India
Sryntek Pharmaceutical Private Limitedthis company₹18.19 Lakh (FY 2025)₹1,7690.1%28.0%Pune, Maharashtra, India
Relivaid Healthcare India Private Limited₹18.18 Lakh (FY 2021)Mumbai, Maharashtra, India
Great Lifesciences Private Limited₹18.15 Lakh (FY 2022)-89.0%Vastral, Gujarat, India
Creata Pharmaceuticals (I) Private Limited₹18.1 Lakh (FY 2024)2.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Sryntek Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sryntek Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sryntek Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27ABICS4752M1ZQMaharashtraActive03 Jun 2022

To see the full GST registrations and return filing status of Sryntek Pharmaceutical Private Limited, buy the company report.

Recent activity

Sryntek Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Santosh Jagatpal Yadav was appointed as Director on 10 May 2022.

AGM
Sryntek Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sryntek Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Santosh Jagatpal Yadav was appointed as Director.
Appointed
Santoshidevi Yadav was appointed as Director.
Incorporation
10 May 2022
Sryntek Pharmaceutical Private Limited was registered on 10 May 2022 with Roc Pune & aged 4 years 5 months as per MCA records.

Frequently asked questions

Sryntek Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 May 2022 (4+ years old) and is registered under CIN U24290PN2022PTC211142.

Sryntek Pharmaceutical has 2 current directors:

The latest financial statements of Sryntek Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Sryntek Pharmaceutical is 27ABICS4752M1ZQ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Sryntek Pharmaceutical is U24290PN2022PTC211142. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sryntek Pharmaceutical was incorporated on 10 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.

The peers of Sryntek Pharmaceutical by revenue are Vijay Remedies Limited, Stepan Laboratories Private Limited, Relivaid Healthcare India Private Limited, Great Lifesciences Private Limited, Creata Pharmaceuticals (I) Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Santosh Jagatpal Yadav was appointed as Director on 10 May 2022. Santoshidevi Yadav was appointed as Director on 10 May 2022.

Yes, Sryntek Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0261867).

The registered office of Sryntek Pharmaceutical is at Milkat No.1627 Shop No.4 Manterwadi Haveli Pune Uruli Dewachi, Maharashtra, India – 412308.

Sryntek Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.